Pd L1 Positive Advanced Triple Negative Breast Cancer clinical trials

Explore recruiting pd l1 positive advanced triple negative breast cancer clinical trials.

Recruiting pd l1 positive advanced triple negative breast cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pd L1 Positive Advanced Triple Negative Breast Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A PHASE II TRIAL EVALUATING THE SAFETY AND EFFICACY OF THE COMBINATION OF ZIMBERELIMAB, DOMVANALIMAB, AND SACITUZUMAB GOVITECAN AS FIRST-LINE THERAPY FOR PD-L1 POSITIVE ADVANCED TRIPLE-NEGATIVE BREAST CANCER (The ADJUNCT Study)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Pd L1 Positive Advanced Triple Negative Breast Cancer trials by city

Pd L1 Positive Advanced Triple Negative Breast Cancer in Toronto Pd L1 Positive Advanced Triple Negative Breast Cancer in Vancouver Pd L1 Positive Advanced Triple Negative Breast Cancer in Montreal Pd L1 Positive Advanced Triple Negative Breast Cancer in Calgary Pd L1 Positive Advanced Triple Negative Breast Cancer in Edmonton Pd L1 Positive Advanced Triple Negative Breast Cancer in Ottawa Pd L1 Positive Advanced Triple Negative Breast Cancer in Winnipeg Pd L1 Positive Advanced Triple Negative Breast Cancer in Quebec City Pd L1 Positive Advanced Triple Negative Breast Cancer in Hamilton Pd L1 Positive Advanced Triple Negative Breast Cancer in Kitchener Pd L1 Positive Advanced Triple Negative Breast Cancer in London Pd L1 Positive Advanced Triple Negative Breast Cancer in Halifax Pd L1 Positive Advanced Triple Negative Breast Cancer in New York Pd L1 Positive Advanced Triple Negative Breast Cancer in Los Angeles Pd L1 Positive Advanced Triple Negative Breast Cancer in Chicago Pd L1 Positive Advanced Triple Negative Breast Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease